TARS
−$72.9K
4,853 sh @ $15
TARS
Tarsus Pharmaceuticals, Inc.
SEC CIK 1819790
$61.86
−0.2% · 90 days
90-day buys
$0
0 open-market
90-day sells
$2.34M
8 open-market
Net insider flow
−$2.34M
Net selling
Filings shown
107
Most recent
Advertisement
At a glance
Over the last 90 days, insiders at TARS have sold a net $2.34M of stock (0 open-market buys vs 8 sells).
Largest recent trade: Rtw Investments, Lp sold $13.49M of TARS, trimming their stake 18%.
Most active filer: Azamian Bobak R., with 51 transactions among the recent filings shown.
Insider transaction history
Form 4 filings for TARS, newest firstTARS
−$122.2K
8,000 sh @ $15
TARS
−$136.3K
9,000 sh @ $15
TARS
−$75K
4,856 sh @ $15
TARS
−$3.6K
240 sh @ $15
Advertisement
TARS
−$116.5K
8,000 sh @ $15
TARS
−$59K
3,904 sh @ $15
TARS
−$13.7K
905 sh @ $15
TARS
−$11K
729 sh @ $15
TARS
−$6.2K
411 sh @ $15
TARS
−$19.5K
1,154 sh @ $17
TARS
−$19.5K
1,165 sh @ $17
TARS
−$19.5K
1,182 sh @ $17
TARS
Lin Elizabeth Yeu, TARS's Director, spent $193K of their own money on 12,040 shares at $16, opening a brand-new position.
+$193K
12,040 sh @ $16
TARS
Lin Elizabeth Yeu, TARS's Director, spent $103.6K of their own money on 6,360 shares at $16, opening a brand-new position.
+$103.6K
6,360 sh @ $16
TARS
−$13.49M
450,000 sh @ $30
TARS
Frazier Life Sciences Ix, L.p., TARS's 10% owner, spent $5M of their own money on 312,500 shares at $16, growing their stake 19%.
+$5M
312,500 sh @ $16
Advertisement
About TARS insider activity
This page tracks every recent Form 4 filed for Tarsus Pharmaceuticals, Inc. with the U.S. Securities and Exchange Commission. Form 4 is the disclosure that company insiders — officers, directors, and holders of more than 10% of the stock — must file within two business days of buying or selling shares.
The summary above nets open-market purchases against open-market sales over the trailing 90 days. Open-market trades (codes P and S) tend to carry the most signal because they reflect a deliberate choice to put money in or take it out, as opposed to routine grants, option exercises, or tax-withholding events. Use the badges on each row to tell them apart, and always confirm details against the original filing before drawing conclusions.
Frequently asked questions
How often is TARS insider data updated?
Continuously. We read from SEC EDGAR, so new Form 4 filings for Tarsus Pharmaceuticals, Inc. usually appear here within minutes of being accepted by the SEC.
What does "net insider flow" mean?
It is the total dollar value of open-market insider purchases minus open-market sales over the last 90 days. A positive number (green) means insiders bought more than they sold; a negative number (red) means the reverse.
Why do some rows show grants or option exercises instead of buys?
Insiders receive stock through compensation as well as buying it outright. Form 4 captures all of these. We label each transaction by its SEC code so you can focus on open-market activity if you prefer.
Is this investment advice?
No. InsiderSource presents public filing data for informational purposes only. Insider activity is one of many factors to consider and is never a recommendation to buy or sell.